SLG
CTIC

Stanley-Laman Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Stanley-Laman Group’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,100
Closed -$14K – 375
2015
Q4 		$14K Buy
+1,100
New +$14K ﹤0.01% 352